GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
7D6I | 7D6I | A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2 | |
7DLH | 7DLH | Crystallization of Cationic Peroxidase from Proso Millet and Identification of Its Phosphatase Active Sites | |
7EJT | Q6FSK0 | Crystal Structure of the Candida Glabrata Glycogen Debranching Enzyme (W470A) in complex with maltoheptaose | |
7EKH | Q9BYF1 | Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 | |
7EKH | P0DTC2 | Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 | |
7FI0 | B2FHL8 | Crystal structure of Multi-functional Polysaccharide lyase Smlt1473 (WT) from Stenotrophomonas maltophilia (strain K279a) in ManA bound form at pH-5.0 | |
7LBV | A0A2B7IY20 | Crystal structure of the Propionibacterium acnes surface sialidase in complex with Neu5Ac2en | |
7MJO | Q63664 | Vascular KATP channel: Kir6.1 SUR2B quatrefoil-like conformation 1 | |
7MJO | Q63563 | Vascular KATP channel: Kir6.1 SUR2B quatrefoil-like conformation 1 | |
7MSG | O43557 | The crystal structure of LIGHT in complex with HVEM and CD160 | |
7MSG | Q92956 | The crystal structure of LIGHT in complex with HVEM and CD160 | |
7MSG | O95971 | The crystal structure of LIGHT in complex with HVEM and CD160 | |
7MXF | P29016 | CD1c with antigen analogue 2 | |
7MXF | P29017 | CD1c with antigen analogue 2 | |
7MXF | P61769 | CD1c with antigen analogue 2 | |
7MZK | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 | |
7MZK | 7MZK | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 | |
7MZM | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 215 | |
7MZM | 7MZM | SARS-CoV-2 receptor binding domain bound to Fab PDI 215 | |
7N1I | A0A0C4MX98 | CryoEM structure of Venezuelan equine encephalitis virus VLP | |
7N5H | P0DTC2 | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7N5H | 7N5H | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7N6U | Q75760 | Structure of uncleaved HIV-1 JR-FL Env glycoprotein trimer in state U1 bound to small Molecule HIV-1 Entry Inhibitor BMS-378806 | |
7OUL | P31224 | BDM88832 inhibitor bound to the transmembrane domain of AcrB-R971A | |
7OUL | 7OUL | BDM88832 inhibitor bound to the transmembrane domain of AcrB-R971A | |
7P1D | Q0CMX0 | Structure of KDNase from Aspergillus Terrerus in complex with 2-keto-3-deoxynononic acid | |
7P1P | P22303 | Crystal structure of human acetylcholinesterase in complex with (E)-3-hydroxy-6-(3-(4-(4-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)propyl)picolinaldehyde oxime | |
7P9V | P08195 | Cryo EM structure of System XC- | |
7P9V | Q9UPY5 | Cryo EM structure of System XC- | |
7PEE | P09758 | Crystal structure of extracellular part of human Trop2 | |
7R84 | Q3UHD1 | Structure of mouse BAI1 (ADGRB1) TSR3 domain in P21 space group | |
7SOD | P0DTC2 | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
7SOD | 7SOD | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
7SY0 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7SY0 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7V7E | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1 | |
7V83 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V83 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V83 | 7V83 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V83 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V83 | 7V83 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V84 | P0DTC2 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V84 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V84 | 7V84 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V84 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V84 | 7V84 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V85 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V85 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V85 | 7V85 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V85 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024